These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 226443)

  • 1. A malignant insulinoma transformed into a glucagonoma syndrome.
    Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
    Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin and C-peptide in plasma and tumor of insulinoma patients.
    Ohneda A; Sakai T; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
    von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
    Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagonoma syndrome. Report of two cases and literature review.
    Binnick AN; Spencer SK; Dennison WL; Horton ES
    Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
    Nesović M; Cirić J; Radojković S; Zarković M; Durović M
    J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
    Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
    Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagonoma tumors and syndrome.
    Montenegro-Rodas F; Samaan NA
    Curr Probl Cancer; 1981 Dec; 6(6):1-54. PubMed ID: 6276079
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant metastatic insulinoma treated with streptozotocin.
    Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An islet cell carcinoma containing glucagon and insulin. Chronic glucagon excess and glucose homeostasis.
    Boden G; Owen OE; Rezvani I; Elfenbein BI; Quickel KE
    Diabetes; 1977 Feb; 26(2):128-37. PubMed ID: 190071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal responses to intravenous and oral glucose tolerance testing in a patient with a gastrinoma and a gastrojejunostomy.
    Massaro RP
    Gastroenterology; 1974 May; 66(5):1058-62. PubMed ID: 4363772
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.
    Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
    Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
    Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
    Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.